Melanoma vaccines: developments over the past 10 years. - Test2 - elhamkhani - TriplyDB

Melanoma vaccines: developments over the past 10 years.

Melanoma vaccines: developments over the past 10 years.

http://www.wikidata.org/entity/Q37892595

about

Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.Advances in immunotherapy for melanoma management.Fotemustine for the treatment of melanoma.Recent progress in canine tumor vaccination: potential applications for human tumor vaccines.Melanoma immunotherapy: historical precedents, recent successes and future prospects.Activation of local and systemic anti-tumor immune responses by ablation of solid tumors with intratumoral electrochemical or alpha radiation treatments.Update on vaccines for high-risk melanoma.Evolving role of tumor antigens for future melanoma therapies.Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches.Protein Expression Analysis of Melanocyte Differentiation Antigen TRP-2.Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.Vaccines in clinical trials: cancer

P2860

Q36067524-636B8155-BB7A-4B8F-B998-C783CB980452 Q37375978-160D9410-9EDA-42E4-B464-AC37D983DF03 Q37955277-5C4BCB3A-4286-4C6D-988F-6A8AEA5EA5E0 Q38068234-8B30FD51-23DD-48A6-A7B6-42673892D162 Q38081911-DB1C07A3-3614-471B-8BE8-7A2493870905 Q38129794-DEAB8FCF-0D7B-41EF-B2DD-0630E5D65BB6 Q38208715-A60AA09C-92DD-4C32-940B-A6CA649FFDBD Q38232855-44D2A9FA-929F-4803-8774-EC4CEE629F06 Q38257363-89845A6C-9FBE-4A5F-8B13-AD7BFF7370BF Q38382073-A4D18798-2666-4473-9628-5F2B758741AB Q47221521-974D7DE8-BEA3-4FDC-9B08-C58A5A355E67 Q57594208-D649B8E3-6935-4EA2-8268-F5D08D19190C

P2860

Melanoma vaccines: developments over the past 10 years.

http://www.wikidata.org/entity/Q37892595

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Melanoma vaccines: developments over the past 10 years.

@en

Melanoma vaccines: developments over the past 10 years.

@nl

type

label

Melanoma vaccines: developments over the past 10 years.

@en

Melanoma vaccines: developments over the past 10 years.

@nl

prefLabel

Melanoma vaccines: developments over the past 10 years.

@en

Melanoma vaccines: developments over the past 10 years.

@nl

P1433

Q37892595-FC6F2247-E847-4AEA-BE76-87F303859E92

P1476

Q37892595-A2B2ED6B-9B1E-4184-AB81-16ADA2F9403F

P2093

Q37892595-09B86FAA-FCA9-4C33-97B1-BBFF913A3AFE

Q37892595-A4ABBA31-43BF-48C8-9204-F51BB452D04C

Q37892595-C1BE196C-E6FC-4B79-A7FF-4D9FBD7A83A6

Q37892595-EEF9EF86-FBFD-4518-9B90-E923D9E92B04

P2860

Q37892595-005AA6BB-0F11-4800-A5C5-A50D8C746056

Q37892595-00BE7A7E-2025-4C3E-9EA7-31ADD102CAD9

Q37892595-01179BB8-910D-49E6-B09C-852C43EBB09B

Q37892595-0525709B-41A6-4294-8EFD-1C74B4BFB121

Q37892595-07331306-7744-44D6-BB76-BA4A784360D8

Q37892595-0799702E-ED78-4631-8FA8-CF8EDA66D12F

Q37892595-0A24B63A-5E6B-4EF0-BDA4-DD605022E3F3

Q37892595-0FF81684-2580-4EFB-A1E8-F893F5E79422

Q37892595-107F6EB4-32C4-4B1A-AAB0-4AA00758C6A8

Q37892595-10D54D45-9275-4652-9E40-FDD1DA15CB9A

P304

Q37892595-B50CB5A7-C4F3-4B14-A29B-7618BBB48944

P31

Q37892595-4DB26D99-4BE9-4808-9A4D-6E20DE596AB0

P356

Q37892595-436F93A0-B5B1-4126-BCC9-776DDB94685E

P433

Q37892595-25BDCA13-3D1A-4171-998D-59FE65564C7B

P478

Q37892595-B4B69FEB-62AF-4D38-B7F7-2F78DA9368A8

P50

Q37892595-215BD96C-421C-41E0-B66E-E03A6AC5D2FF

Q37892595-5C9729AD-B690-4029-A8C6-84CAD282F6F2

P577

Q37892595-ED2DABC3-F699-43F4-A651-14E063A19A17

P698

Q37892595-8DA7AF74-18F2-49AD-A226-BE932AC5812D

P356

P1433

Expert Review of Vaccines

P1476

Melanoma vaccines: developments over the past 10 years

@en

P2093

Ashley Knights

http://www.w3.org/2001/XMLSchema#string

Ian D Davis

http://www.w3.org/2001/XMLSchema#string

Oliver Klein

http://www.w3.org/2001/XMLSchema#string

Weisan Chen

http://www.w3.org/2001/XMLSchema#string

P2860

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

Cancer immunotherapy: moving beyond current vaccines

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

Improved endpoints for cancer immunotherapy trials

Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

The consensus coding sequences of human breast and colorectal cancers

P304

853-873

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERV.11.74

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21692705

http://www.w3.org/2001/XMLSchema#string